Bountogo M, Zakane A, Ouedraogo TA, Ouermi L, Compaoré G, Compaoré A, Coulibaly B, Koueta F, Burroughs HR, Fetterman I et al..  2025.  Azithromycin as adjunctive treatment for uncomplicated severe acute malnutrition (AMOUR): study protocol for a double-masked randomised controlled trial.. BMJ Open. 15(7):e104591.

Arzika AM, Amza A, Ousmane S, Maliki R, Almou I, Galo N, Harouna N, Mankara A, Aichatou B, Boubacar O et al..  2025.  Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions.. medRxiv. 

Coulibaly B, Sie A, Ouattara M, Bountogo M, Compaoré G, Compaoré A, Nikiema M, Sibiri NDembélé, Tiansi JNankoné, Lebas E et al..  2025.  Malaria Parasitemia after Mass Distribution of Azithromycin to Prevent Child Mortality in Burkina Faso: Results from a Cluster Randomized Trial.. Am J Trop Med Hyg. 

Arzika AM, Amza A, Maliki R, Aichatou B, Bello IMamane, Beidi D, Galo N, Harouna N, Karamba AM, Mahamadou S et al..  2025.  Spillover of Azithromycin Mass Drug Administration and Child Survival: A Secondary Analysis of a Cluster-Randomized Clinical Trial.. JAMA Netw Open. 8(7):e2519693.

Yan D, N Prajna V, Lalitha P, Sansanayudh W, Satitpitakul V, Laovirojjanakul W, Chaudhary M, Bountogo M, Sie A, Coulibaly B et al..  2024.  Association of weather variables with pathogens contributing to conjunctivitis worldwide.. Clin Infect Dis. 

O'Brien KS, Arzika AM, Amza A, Maliki R, Aichatou B, Bello IMamane, Beidi D, Galo N, Harouna N, Karamba AM et al..  2024.  Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.. N Engl J Med. 391(8):699-709.

Doan T, Liu Z, Sie A, Dah C, Bountogo M, Ouattara M, Coulibaly B, Kiemde D, Zonou G, Nebie E et al..  2024.  Gut Microbiome Diversity and Antimicrobial Resistance After a Single Dose of Oral Azithromycin in Children: A Randomized Placebo-Controlled Trial.. Am J Trop Med Hyg. 

Oldenburg CE, Ouattara M, Bountogo M, Boudo V, Ouedraogo T, Compaoré G, Dah C, Zakane A, Coulibaly B, Bagagnan C et al..  2024.  Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso: The CHAT Randomized Clinical Trial.. JAMA. 331(6):482-490.

Bountogo M, Ouermi L, Dah C, Sie A, Coulibaly B, Zakane A, Ouedraogo T, Ouattara M, Lebas E, Fetterman I et al..  2024.  Neonatal Azithromycin Exposure and Childhood Growth: Long-Term Follow-Up of a Randomized Controlled Trial.. Am J Trop Med Hyg. 

Arzika AM, Abdou A, Maliki R, Beido N, Kadri B, Harouna AN, Galo AN, Alio MK, Lebas E, Oldenburg CE et al..  2024.  Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).. PLoS Med. 21(5):e1004386.

Amza A, Nassirou B, Kadri B, Ali S, Mariama B, Ibrahim CMamadou, Roufaye LAboubacar, Lebas E, Colby E, Zhong L et al..  2023.  Comprehensive Profile of Pathogens and Antimicrobial Resistance in Conjunctivitis Cases from Niger.. Am J Trop Med Hyg. 109(6):1333-1338.

Hazel A, Arzika AM, Abdou A, Lebas E, Porco TC, Maliki R, Doan T, Lietman TM, Keenan JD, Blumberg S.  2023.  Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger.. Am J Trop Med Hyg. 

Ousmane S, Kollo IA, Jambou R, Boubacar R, Arzika AM, Maliki R, Amza A, Liu Z, Lebas E, Colby E et al..  2023.  Wastewater-Based Surveillance of Antimicrobial Resistance in Niger: An Exploratory Study.. Am J Trop Med Hyg. 

Bountogo M, Sie A, Coulibaly B, Ruder K, Chen C, Zhong L, Colby E, Lebas E, Deiner M, Hinterwirth A et al..  2022.  Deep sequencing analysis of acute conjunctivitis in Burkina Faso, Africa.. Int Health. 

Arzika AM, Maliki R, E Goodhew B, Rogier E, Priest JW, Lebas E, O'Brien KS, Le V, Oldenburg CE, Doan T et al..  2022.  Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger.. Nat Commun. 13(1):976.

Coulibaly B, Kiemde D, Zonou G, Sie A, Dah C, Bountogo M, Brogdon J, Hu H, Lebas E, Porco TC et al..  2022.  Effect of Single-dose Azithromycin on Pneumococcal Carriage and Resistance: A Randomized Controlled Trial.. Pediatr Infect Dis J. 41(9):728-730.

Oldenburg CE, Hinterwirth A, Dah C, Millogo O, Coulibaly B, Ouédraogo M, Sie A, Chen C, Zhong L, Ruder K et al..  2022.  Gut Microbiome among Children with Uncomplicated Severe Acute Malnutrition in a Randomized Controlled Trial of Azithromycin versus Amoxicillin.. Am J Trop Med Hyg. 

Oldenburg CE, Hinterwirth A, Ourohiré M, Dah C, Ouédraogo M, Sie A, Boudo V, Chen C, Ruder K, Zhong L et al..  2022.  Gut Resistome after Antibiotics among Children with Uncomplicated Severe Acute Malnutrition: A Randomized Controlled Trial.. Am J Trop Med Hyg. 107(1):59-64.

Oldenburg CE, Sie A, Bountogo M, Zakane A, Compaoré G, Ouedraogo T, Koueta F, Lebas E, Brogdon J, Nyatigo F et al..  2022.  Neonatal azithromycin administration for prevention of infant mortality.. NEJM Evid. 1(4):EVIDoa2100054.

O'Brien KS, Arzika AM, Amza A, Maliki R, Ousmane S, Kadri B, Nassirou B, Mankara AKaramba, Harouna ANaser, Colby E et al..  2021.  Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).. BMC Public Health. 21(1):822.

Coulibaly B, Sie A, Dah C, Bountogo M, Ouattara M, Compaoré A, Nikiema M, Tiansi JNankoné, Sibiri NDembélé, Brogdon JM et al..  2021.  Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial.. Malar J. 20(1):360.

Oldenburg CE, Pinsky BA, Brogdon J, Chen C, Ruder K, Zhong L, Nyatigo F, Cook CA, Hinterwirth A, Lebas E et al..  2021.  Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial.. JAMA. 

Arzika AM, Maliki R, Abdou A, Mankara AK, Harouna AN, Cook C, Hinterwirth A, Worden L, Zhong L, Chen C et al..  2021.  Gut resistome of preschool children after prolonged mass azithromycin distribution: a cluster-randomized trial.. Clin Infect Dis. 

Brogdon JM, Sie A, N Dah C, Ouermi L, Coulibaly B, Lebas E, Zhong L, Chen C, Lietman TM, Keenan JD et al..  2021.  Poultry Ownership and Genetic Antibiotic Resistance Determinants in the Gut of Preschool Children.. Am J Trop Med Hyg. 

Sie A, Coulibaly B, Dah C, Bountogo M, Ouattara M, Compaoré G, Brogdon JM, Godwin WW, Lebas E, Doan T et al..  2021.  Single-dose azithromycin for child growth in Burkina Faso: a randomized controlled trial.. BMC Pediatr. 21(1):130.

Sie A, Dah C, Bountogo M, Ouattara M, Nebie E, Coulibaly B, Brogdon JM, Godwin WW, Lebas E, Doan T et al..  2020.  Adverse Events and Clinic Visits following a Single Dose of Oral Azithromycin among Preschool Children: A Randomized Placebo-Controlled Trial.. Am J Trop Med Hyg. 

Digitale J, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Bärnighausen T, Lebas E, Arzika AM, Glymour MMaria et al..  2020.  Gut Bacterial Diversity and Growth among Preschool Children in Burkina Faso.. Am J Trop Med Hyg. 103(6):2568-2573.

Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong L, Chen C, Cook C, Lebas E et al..  2020.  Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.. N Engl J Med. 383(20):1941-1950.

Sie A, Ouattara M, Bountogo M, Bagagnan C, Coulibaly B, Boudo V, Lebas E, Brogdon JM, Lin Y, Bärnighausen T et al..  2019.  A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol.. Trials. 20(1):675.

Oldenburg CE, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Bärnighausen T, Lebas E, Arzika AM, Cummings S et al..  2019.  Indirect Effect of Azithromycin Use on the Intestinal Microbiome Diversity of Untreated Children: A Randomized Trial.. Open Forum Infect Dis. 6(3):ofz061.

Keenan JD, Arzika AM, Maliki R, Boubacar N, Adamou SElh, Ali MMoussa, Cook C, Lebas E, Lin Y, Ray KJ et al..  2019.  Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.. N Engl J Med. 380(23):2207-2214.

Sie A, Bountogo M, Nebie E, Ouattara M, Coulibaly B, Bagagnan C, Zabre P, Lebas E, Brogdon J, Godwin WW et al..  2019.  Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial.. BMJ Open. 9(9):e031162.

Lalitha P, Seitzman GD, Kotecha R, Hinterwirth A, Chen C, Zhong L, Cummings S, Lebas E, Sahoo MK, Pinsky BA et al..  2019.  Unbiased Pathogen Detection and Host Gene Profiling for Conjunctivitis.. Ophthalmology. 126(8):1090-1094.

Keenan JD, Bailey RL, West SK, Arzika AM, Hart J, Weaver J, Kalua K, Mrango Z, Ray KJ, Cook C et al..  2018.  Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.. N Engl J Med. 378(17):1583-1592.

Oldenburg CE, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Bärnighausen T, Ray KJ, Zhong L, Cummings S et al..  2018.  Effect of Commonly Used Pediatric Antibiotics on Gut Microbial Diversity in Preschool Children in Burkina Faso: A Randomized Clinical Trial.. Open Forum Infect Dis. 5(11):ofy289.